Post-Market Surveillance
This page provides a plain English reference for post-market surveillance under China's NMPA regulatory framework. Full content to be completed during editorial review.
Regulatory basisβ
- MDSAR 2021 (State Council Order No. 739)
- Adverse Event Monitoring & Re-evaluation Measures
- Relevant NMPA orders and announcements
Key requirementsβ
Requirements for post-market surveillance are set out in MDSAR 2021 and implementing measures. See Legislation & Regulations for the full legislative index.
Official Sources
- NMPA β www.nmpa.gov.cn
- CMDE β www.cmde.org.cn
- NMPA Medical Device Registration Query β datasearch.nmpa.gov.cn
Disclaimer
Content on this site is written with AI assistance and is intended as a navigation aid only. Always verify against official NMPA sources before making regulatory decisions. Not affiliated with NMPA or any Chinese Government body. Not legal or regulatory advice.